Europe Biosimilars Market is poised to reach USD 30.12 billion in 2022
Europe Biosimilars Market by type, by Technology, by Application (Oncology and Blood Diseases, Growth hormone deficiencies and others), by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
(EMAILWIRE.COM, November 28, 2017 ) According to the report Europe Biosimilars Market, published by Market Data Forecast, the Europe market is projected to reach USD 9.78 billion by 2022, at a CAGR of 33% from 2017 to 2022.
Biosimilars industry are biological medical product which is an alike copy of original product produced by another company. Biosimilars have molecular complexity unlike small molecule generic drugs.
Get a comprehensive overview of the Europe Biosimilars Market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/
Europe Biosimilars Market: Drivers & Restraints
Increasing geriatric population, growing demand for biosimilars and increasing incidence of diabetes and chronic disorders are the primary factors driving the growth of the market. Also increasing initiatives by government is expected to boost the market.
However, complexities associated with the production of biosimilars is a major factor hampering the growth of the market.
Get accurate market forecast and analysis on the Europe Biosimilars Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/request-sample
Europe Biosimilars Market: Segmentation
By Type
• Protein
• Insulin
• Human Growth Hormones
• Granulocyte Colony-stimulating Factor (G-CSF)
• Interferons
• Recombinant Glycosylated Proteins
• Erythropoietin
• Monoclonal Antibodies
• Follitropin
• Recombinant Peptides
• Glucagon
• Calcitonin
By Technology
• Mass Spectroscopy
• Chromatography
• Monoclonal Antibody Technology
• Recombinant DNA Technology
• Nuclear magnetic resonance (NMR) technology
• Electrophoresis
• Bioassay
By Application
• Oncology diseases
• Blood disorders
• Growth hormone deficiencies
• Chronic and autoimmune diseases
• Others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/customize-report
Europe Biosimilars Market: Overview
In 2017, the Recombinant Non-glycosylated Proteins is expected to have the largest share of the market. Rising incidence of diabetes and cost-effectiveness are some factors that have boosted this category. In 2017 Oncology is anticipated to have fastest growth.
The Europe Biosimilars Market is dominated by Germany in 2017. Germany was followed next in line by United Kingdom.
Europe Biosimilars Market: Key Players
The Europe Biosimilars Market is highly competitive with a large number of players. Some of the major Companies are Novartis (Sandoz), Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals, Inc., and LG Life Sciences. Other companies operating in this market are Celltrion, Merck Serono (Merck Group), Biogen idec, Inc., Biocon, Hospira, and Genentech (Roche Group).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Biosimilars industry are biological medical product which is an alike copy of original product produced by another company. Biosimilars have molecular complexity unlike small molecule generic drugs.
Get a comprehensive overview of the Europe Biosimilars Market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/
Europe Biosimilars Market: Drivers & Restraints
Increasing geriatric population, growing demand for biosimilars and increasing incidence of diabetes and chronic disorders are the primary factors driving the growth of the market. Also increasing initiatives by government is expected to boost the market.
However, complexities associated with the production of biosimilars is a major factor hampering the growth of the market.
Get accurate market forecast and analysis on the Europe Biosimilars Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/request-sample
Europe Biosimilars Market: Segmentation
By Type
• Protein
• Insulin
• Human Growth Hormones
• Granulocyte Colony-stimulating Factor (G-CSF)
• Interferons
• Recombinant Glycosylated Proteins
• Erythropoietin
• Monoclonal Antibodies
• Follitropin
• Recombinant Peptides
• Glucagon
• Calcitonin
By Technology
• Mass Spectroscopy
• Chromatography
• Monoclonal Antibody Technology
• Recombinant DNA Technology
• Nuclear magnetic resonance (NMR) technology
• Electrophoresis
• Bioassay
By Application
• Oncology diseases
• Blood disorders
• Growth hormone deficiencies
• Chronic and autoimmune diseases
• Others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/customize-report
Europe Biosimilars Market: Overview
In 2017, the Recombinant Non-glycosylated Proteins is expected to have the largest share of the market. Rising incidence of diabetes and cost-effectiveness are some factors that have boosted this category. In 2017 Oncology is anticipated to have fastest growth.
The Europe Biosimilars Market is dominated by Germany in 2017. Germany was followed next in line by United Kingdom.
Europe Biosimilars Market: Key Players
The Europe Biosimilars Market is highly competitive with a large number of players. Some of the major Companies are Novartis (Sandoz), Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals, Inc., and LG Life Sciences. Other companies operating in this market are Celltrion, Merck Serono (Merck Group), Biogen idec, Inc., Biocon, Hospira, and Genentech (Roche Group).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results